Quality White Papers & Case Studies

  1. Sample Preparation Automation For Immunosuppressant Drug Analysis 10/10/2025

    Discover how automated sample prep for immunosuppressant drug analysis improves accuracy, reduces contamination, and streamlines LC-MS/MS workflows.

  2. Calculating The ROI Of EAM/CMMS For Pharma Manufacturers And CDMOs 10/6/2025

    Learn how modern EAM and CMMS systems help pharma manufacturers reduce risk, improve compliance, and cut costs, as well as nine signs it’s time to move beyond outdated asset management practices.

  3. A Powerful Non-Destructive Tool For Tablet Characterization 10/6/2025

    Discover how X-ray micro-CT provides vital, non-destructive analysis of a tablet’s internal 3D physical structure. This structural insight is essential for troubleshooting defects and confirming performance.

  4. Simplify Cell Line Development 10/1/2025

    Explore a streamlined method for isolating viable single cells using microfluidic dispensing and whole-well imaging that is designed to improve clonality, cell health, and reproducibility.

  5. Molecular Approaches To Streamline Cell Therapy Product Analytical Testing 9/26/2025

    Learn how rapid molecular methods of cell therapy testing like qPCR for mycoplasma, sterility, and lentiviral quantification are key to accelerating product release and timely treatment delivery.

  6. Advances In Analytical Method Selection And Technology Transfer 9/26/2025

    Successful analytical method transfer is crucial for product quality and regulatory compliance. Learn best practices for tech transfer, including how gap assessments mitigate common risks and streamline bioprocessing.

  7. Streamlining Data For Efficient Therapeutic Manufacturing 9/26/2025

    An integrated solution for impurity and sterility analysis streamlines data, supports regulatory compliance, and uses built-in algorithms to deliver accurate, actionable results quickly.

  8. Select The Best Analyte: A Guide To Effective Mycoplasma Testing 9/24/2025

    As you build a Mycoplasma testing strategy to ensure drug safety, there are three analyte types to choose from: live Mycoplasma, RNA, and genomic DNA, each offering distinct advantages.

  9. A Risk-Based Approach To Plasmid DNA And mRNA Process Development 9/23/2025

    Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.

  10. Pharma Company Digitizes Paper Logbooks To Increase Data Accessibility 9/18/2025

    A top pharma producer modernized its operations by digitizing paper-based logbooks. Discover how this shift supports compliance and scalability across global manufacturing environments.